GlobeNewswire by notified

Alternus Clean Energy, Inc. Reports FY 2023 Financial Results


•  Revenue up by 17.5% YoY
•  Gross profit up by 25% YoY

FORT MILL, S.C., April 15, 2024 (GLOBE NEWSWIRE) -- Utility-scale transatlantic clean energy independent power producer Alternus Clean Energy, Inc. (NASDAQ: ALCE) (“Alternus” or the “Company”) today announced its audited financial results for the full year 2023 under US GAAP format. The 2023 financial report is included in a Form 10-K filed with the Securities and Exchange Commission. The 2023 financial report is available to view on the Alternus’ website at

Company Highlights:

  • Increase in revenue from by 17.5% YoY;
  • Increase in revenue offtake by 3.8% YoY;
  • Debt reduced by $77 million subsequent to balance sheet;
  • Total of 165 GWH of clean energy produced in 2023, further offsetting global CO2 emissions;
  • Completed business combination agreement with Clean Earth Acquisitions Corp., (“Clean Earth”) priorly listed as “CLIN”, “CLINW”, and “CLINU” over NASDAQ;
  • Listed on NASDAQ in December 2023 under the ticker symbol “ALCE”;
  • Divestment of non-strategic operating assets in Poland and the Netherlands, reducing debt by over $75M;
  • Net loss of $69.5M, due primarily to one-time events including, $15.8M related to divestment of projects in non-core countries, $16.6M for fair value movement related to the forward purchase agreement, $11.2M related to the Solis bond waiver fees, and $5.5M related to loss on disposal of assets.

Commenting on the results, Vincent Browne, Chairman and Group CEO said:

“In 2023, we focused on a strategic business realignment and consolidation, refining our core operations to pave the way for further growth in key high-potential markets across the US and Europe. One standout moment was our successful merger with Clean Earth Acquisitions Corp (CLIN), culminating in our Nasdaq listing (NASDAQ: “ALCE”)—a significant achievement that fills us with pride. Now, equipped with renewed energy and resolve, we're poised to increase our impact, broaden our scope, and ignite further growth in our business. We remain focused on our goal of reaching 3GW of operational assets within five years.”

Alternus Chief Financial Officer Joseph E. Duey added:

“2023 represented a year of strategic development for Alternus. We announced our listing on Nasdaq in December 2023 and are now well positioned organisationally to deliver on our goals. Our 2023 balance sheet is reflective of a conservative position. Subsequent to this balance sheet we have reduced debt by $77 million. We are now in a process of refinancing assets over a longer-term period, to align our debt with the longevity of our continuing asset portfolio. Once restructured the debt will be spread out of our balance sheet. We also have a secure pipeline of potential acquisition projects to execute on within the coming 12-18 months and are confident that we have the ability to access equity capital as needed and fund the growth plan we have in place.”

Results Underpinned by a Diversified Portfolio of Assets

The table below summarises the Company’s portfolio of assets as of December 31, 2023.

United States3.88.7%

The Company announced the divestment of non-core assets in late 2023, in line with our renewed strategy to focus on strategic markets across Europe and the US. A focus will be on delivering on the advanced stage development pipeline portfolio of over 300MW in Italy and Spain and on executing on near-term acquisitions of both operating and ready-to-build projects from a growing pipeline of ‘equity light’ projects in the US.

It was announced in 2023 that Alternus acquired 32MWp solar PV project in Tennessee, USA, known as ‘Dancing Horse.’ Dancing Horse is expected to start operating in Q1 2025 and should produce annual revenue of approximately $2.3 million when fully operational. 100% of the offtake from this facility is secured by 30-year power purchase agreements with two regional utilities.

The Company also announced a planned expansion in Spain with the acquisition of Solar PV projects totalling 32 MWp of Solar PV projects in Valencia, Spain, known as the NF Projects. The portfolio consists of six projects in total: five of which, totalling 24.4 MWp, are expected to reach operation in Q2 2024, with the remaining project expected to achieve operation in Q1 2025.

Once operating, 10-year average annual revenues from the initial portfolio of five will be approximately $2.3 million, going to $2.8 million once all are connected.

Business Combination and Nasdaq Listing

The Company successfully started trading over Nasdaq on the 26th of December 2023 under the ticker (NASDAQ: ALCE) following a successful business combination with its predecessor, Clean Earth. Under the terms of the business combination agreement, the Company acquired the majority of Alternus Energy Group PLC, a company incorporated under the laws of Ireland (“AEG”)’s assets, with simultaneously issuing it common stock, in turn making it the largest shareholder in the Company. AEG continues to exist as a separate legal entity and continues to trade on the Euronext Growth stock market in Oslo under the ticker (OSE: ALT). The completion of the business combination with Clean Earth and resultant listing on Nasdaq, is a key strategic pillar in our commitment towards a sustainable future.

The below table summarises the Company’s financial performance for the full year 2023, compared to the full year 2022.

20232022$ Change% Change
Cost of Sales(4.5)(4.4)(0.1)2%
Gross Profit15.612.72.923%
Gross Margin78%74%3%5%
Selling and General Expenses(11.2)(5.7)(5.5)96%
Interest Charges(18.6)(10.3)(8.3)81%
Depreciation and amortization(3.7)(3.7)0%
Total Other Expense(35.8)(11.6)(24.2)209%
Net Loss(53.7)(18.6)(35.1)189%

Subsequent Events Strengthen Outlook and Deliver on Sustained Growth

After the close of the year, the Company announced material developments that it believes strengthens its growth position.

Close of Sale in the Netherlands

The Company announced the closing of the sale of 100% of the share capital in Zoonepark Rilland B.V. to Theia on the 21st of February 2024. This activity was a planned activity in line with the divestment of non-core projects within the operating portfolio.

Green Bond Covenant Waiver

The bondholders voted to approve the resolutions for the extension of the waivers and the maturity date to the Bond Terms and the maturity date until 30 April 2024, with the right to further extend to May 31, 2024, at the Bond Trustee’s discretion, and thereafter on a month-to-month basis to 29 November 2024 at the Bond Trustee’s discretion and approval from a majority of Bondholders.

Project Development

On 4 April 2024 it was announced that Alternus had entered into a joint venture with Acadia Energy (Acadeia), a microgrid and renewable energy developer, to develop 200MW of Microgrid Projects in New York State. The venture will focus on developing and operating a portfolio of microgrid projects over the next 2-3 years. Under the terms of the joint venture, Alternus will hold a 51% majority ownership stake in the projects.

About Alternus Clean Energy, Inc.

Alternus is a transatlantic clean energy independent power producer. Headquartered in the United States, we currently develop, install, own, and operate utility-scale solar parks in the North America and Europe. Our highly motivated and dynamic team at Alternus have achieved rapid growth in recent years. Building on this, our goal is to reach 3GW of operating projects within five years through continued organic development activities and targeted strategic opportunities. Our vision is to become a leading provider of 24/7 clean energy delivering a sustainable future of renewable power with people and planet in harmony. For more information visit

Forward-Looking Statements

Certain information contained in this release, including any information on the Company’s plans or future financial or operating performance and other statements that express the Company’s management’s expectations or estimates of future performance, constitute forward-looking statements. When used in this notice, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Such statements are based on a number of estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond the control of the Company. The Company cautions that such forward-looking statements involve known and unknown risks and other factors that may cause the actual financial results, performance, or achievements of the Company to differ materially from the Company’s estimated future results, performance or achievements expressed or implied by the forward-looking statements. These statements should not be relied upon as representing Alternus’ assessments of any date after the date of this release. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

For More Information:

Alternus Investors:
Alternus Clean Energy
+1 (913) 815-1557

Alternus Media:
The Blueshirt Group
+1 (323) 240-5796

(in thousands, except share and per share data)
As of
December 31,
As of
December 31,
Current Assets
Cash and cash equivalents$4,618$705
Accounts receivable, net6513,335
Unbilled energy incentives earned5,6074,954
Prepaid expenses and other current assets3,3441,482
Taxes recoverable6311,388
Restricted Cash19,161
Current discontinued assets held for sale80,943
Total Current Assets114,95511,864
Property and equipment, net61,30268,953
Right of use asset1,3301,004
Restricted cash6,598
Other receivable1,483
Capitalized development cost and other long-term assets, net6,2162,146
Non-current discontinued assets held for sale87,750
Total Assets$185,286$178,315
Current Liabilities
Accounts payable$5,084$1,138
Accrued liabilities24,4103,471
Taxes payable14616
Deferred income5,6074,954
Operating lease liability17575
Green bonds166,122
Convertible and non-convertible promissory notes, net of debt issuance costs31,420
Current discontinued liabilities held for sale14,259
Total Current Liabilities247,09110,254
Green bonds149,481
Convertible and non-convertible promissory notes, net of debt issuance costs9,214
Operating lease liability, net of current portion1,252960
Asset retirement obligations197397
Non-current discontinued liabilities held for sale10,591
Total Liabilities248,540180,897
Shareholders’ Deficit
Preferred stock, $0.0001 par value, 1,000,000 authorized as of December 31, 2023. 0 issued and outstanding as of December 31, 2023.
Common Stock, $0.0001 par value, 150,000,000 authorized as of December 31, 2023; 71,905,363 issued and outstanding as of December 31, 2023, and 57,500,000 issued and outstanding as of December 31, 2022.76
Additional paid in capital27,87419,797
Foreign Currency Translation Reserve(2,925)(3,639)
Accumulated deficit(88,210)(18,746)
Total Shareholders’ Deficit(63,254)(2,582)
Total Liabilities and Shareholder’ Deficit$185,286$178,315

(in thousands, except share and per share data)
Year Ended December 31
Operating Expenses
Cost of revenues(4,468)(4,439)
Selling, general and administrative(11,228)(5,720)
Depreciation, amortization, and accretion(3,657)(3,677)
Development Costs(798)(11,372)
Loss on disposal of assets(5,501)(79)
Total operating expenses(25,652)(25,287)
Loss from operations(5,568)(8,198)
Other income/(expense):
Interest expense(18,562)(10,256)
Fair value movement of FPA Asset(16,642)
Solis bond waiver fee(11,232)
Other expense(1,642)(684)
Other income9569
Total other expenses(48,069)(10,371)
Loss before provision for income taxes(53,637)(18,569)
Income taxes(15)
Net loss from continuing operations(53,652)(18,569)
Discontinued operations:
Income/(loss) from operations of discontinued business component(3,885)141
Impairment loss recognized on the remeasurement to fair value less costs to sell(11,766)
Income tax(161)(21)
Net income/(loss) from discontinued operations(15,812)120
Net loss$(69,464)$(18,449)
Net loss attributable to common stockholders, basic(53,652)(18,569)
Net loss per share attributable to common stockholders, basic(0.93)(0.32)
Net loss per share attributable to common stockholders, diluted(0.93)(0.32)
Weighted-average common stock outstanding, basic57,862,59857,500,000
Weighted-average common stock outstanding, diluted57,862,59857,500,000
Comprehensive loss:
Net loss$(69,464)$(18,449)
Foreign currency translation adjustment714(992)
Comprehensive loss$(68,750)$(19,441)
To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Subsea7 awarded a contract for the Belinda field in the UK North Sea25.5.2024 14:01:09 CEST | Press release

Luxembourg – 25 May 2024 - Subsea7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by Serica Energy, for the Belinda field development south-east of the Triton FPSO. The Belinda field is operated by Serica Energy and located approximately 190 kilometres east of Aberdeen in the UK Central North Sea, with a water depth of 95 metres. The contract scope includes project management, engineering, procurement, construction and installation (EPCI) of a 5-kilometre 8” production pipeline with a 3” piggy-backed gas lift line and an electro-hydraulic controls (EHC) umbilical. Subsea7’s scope also includes associated subsea structures and tie-ins to the Triton Floating Production Storage & Offloading (FPSO) vessel operated by Dana Petroleum, via an existing production manifold near the Triton riser base and for controls at the Evelyn valve skid. Project management and engineering work will commence immediately in Aberdeen. The offshore activities are scheduled

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio25.5.2024 12:15:00 CEST | Press release

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor,demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs. placebo + supportive care at 36 weeks1 Endothelin A (ETA) receptor activation contributes to elevated proteinuria in IgAN2-5; atrasentan is a potent, selective ETA receptor antagonist with potential to reduce persistent proteinuria and preserve kidney function for a broad patient population1 IgAN is a heterogeneous, progressive, rare kidney disease with a need for effective, targeted therapies6,7; up to 30% of patients with persistent proteinuria (≥1 g/day) progress to kidney failure within 10 years8 Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression Basel, May 25, 2024 – Novartis today presented results from a pre-specified interim analysis of the Phase III ALIGN study of atr

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo25.5.2024 12:00:00 CEST | Press release

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2,3Fabhalta showed a favorable safety profile with no new safety signals1C3G, an ultra-rare kidney disease caused by alternative complement pathway overactivation, progresses to kidney failure in ∼50% of patients within 10 years4-7; currently there are no treatments approved for C3G7-9 Fabhalta, an oral Factor B inhibitor of the alternative complement pathway, selectively targets the underlying cause of C3G1; late-stage development program ongoing across several other rare diseases10-13 Basel, May 25, 2024 – Novartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European Renal Association (ERA) Congress1. Patients treated with Fabhalta in addition to support

Metasphere Labs Announces Development of Innovative Carbon Credit Protocol for Grid-Scale Batteries24.5.2024 22:05:00 CEST | Press release

VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., "Metasphere" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is excited to announce an innovative initiative aimed at accelerating the decarbonization of the electricity grid through the development of a pioneering carbon credit protocol for grid-scale batteries. Innovative Carbon Credit Protocol The Company is committed to leveraging advanced technology to address critical environmental challenges. The new carbon credit protocol will enable grid-scale batteries to monetize their environmental attributes by generating carbon credits for the carbon reductions achieved through optimized battery operations. This protocol is designed to incentivize the deployment and operation of grid-scale batteries, ensuring they play a pivotal role in the transition to a clean energy future. Submission to Pure Sky Carbon Credit Registry The Company intends to submit this pr

Nokia Corporation: Repurchase of own shares on 24.05.202424.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 24 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 24.05.2024 Espoo, Finland – On 24 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL362,1533.55CEUX--BATE--AQEU--TQEX--Total362,1533.55 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

HiddenA line styled icon from Orion Icon Library.Eye